Mahamaya Lifesciences Reports No Promoter Share Encumbrance for FY26

Mahamaya Lifesciences filed a regulatory disclosure confirming no encumbrance on promoter shares for FY 2025-26.
The disclosure, made under SEBI's takeover regulations, was submitted to the BSE on April 3, 2026.
The company's promoter, Krishnamurthy Ganesan, declared no encumbrance was created on promoter-held shares during the financial year.